Skip to main content
You're viewing the free public version. Create a free account for full research and member tools. Join free
Research Abstract Animal Study

A study on Glycyrrhiza uralensis polysaccharide: The structure elucidation, anti-inflammation effects and treatment mechanism of LPS-induced pneumonia.

A study on Glycyrrhiza uralensis polysaccharide: The structure elucidation, anti-inflammation effects and treatment mechanism of LPS-induced pneumonia mice.

0:00 / 0:00
0:00 / 0:00

Sign in to access this feature

Create a free account or sign in to use AI summaries, listen to articles, download PDFs, and save to your library.

242 views
Share:

Abstract

Acute lung injury (ALI) is a life-threatening inflammatory pulmonary disorder characterised by diffuse alveolar damage, pulmonary oedema, and excessive immune responses. This study aimed to investigate the therapeutic potential of a purified polysaccharide, Glycyrrhiza polysaccharide fraction 2 (GCP-2), derived from Glycyrrhiza uralensis (liquorice), in a murine model of LPS-induced ALI. GCP-2 was obtained through a multi-step purification process involving aqueous extraction, ethanol precipitation, ion-exchange chromatography, and size-exclusion chromatography. ALI was induced in mice via intranasal administration of lipopolysaccharide (LPS), followed by GCP-2 treatment. Key outcomes were assessed using ELISA, qPCR, histopathology, and western blotting, while gut microbiota changes were evaluated by 16S rRNA sequencing. The results demonstrated that GCP-2 significantly alleviated lung injury, reduced pulmonary and systemic levels of pro-inflammatory cytokines, restored barrier-related proteins such as Zonula occludens-1 (ZO-1) and occludin, and improved histopathological features. Mechanistic studies revealed that these effects were mediated through the selective inhibition of the TLR4/NF-κB signalling pathway. Additionally, GCP-2 modulated gut microbiota composition by increasing beneficial taxa such as Bacteroidetes, Lactobacillus, and Bifidobacteria, while suppressing Firmicutes and Proteobacteria. These findings suggest that GCP-2 is a safe and effective plant-derived polysaccharide that mitigates LPS-induced ALI through anti-inflammatory and gut-lung axis regulatory mechanisms, supporting its potential as a therapeutic candidate for treating inflammatory lung diseases.

Affiliation

Yue Yu

External References

PubMed ID:
41205946

Comments

Sign in or create a free account to join the conversation.

Sign in to comment

Be the first to comment.

More Research Abstracts

View All Abstracts
Human Study

Air pollution and risk of 32 health conditions: outcome-wide analyses in a population-based prospective cohort.

Sep 10, 2024 Hanwen Zhou, Feng Hong, Lele Wang, Xuewei Tang, Bing Guo, Yuying Luo, Hui Yu, Deqiang Mao, Ting Liu, Yuemei Feng, Yangji Baima, Juying Zhang, Xing Zhao,

BMC Med

Trusted By Professionals and Teams:

The National Health Federation
Stand For Health Freedom
Global Healing Institute
Global Wellness Forum
MAHA Action
Myers Detox
Natural News
Mercola.com

Unlock Evidence-Based Health Research

Join 500,000+ members accessing 10,000+ natural health topics.

Subscribe to our informative Newsletter & Receive

Cancer Fighting Foods Ebook

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of GreenMedInfo or its staff.